Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone.

MLA

Merouani, Aicha, et al. “Increased Nephrotoxicity of Combination Taxol and Cisplatin Chemotherapy in Gynecologic Cancers as Compared to Cisplatin Alone.” American Journal of Nephrology, vol. 17, no. 1, Jan. 1997, pp. 53–58. EBSCOhost, https://doi.org/10.1159/000169072.

APA

Merouani, A., Davidson, S. A., Schrier, R. W., Merouani, A., Davidson, S. A., & Schrier, R. W. (1997). Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone. American Journal of Nephrology, 17(1), 53–58. https://doi.org/10.1159/000169072

Chicago

Merouani, Aicha, Susan A. Davidson, Robert W. Schrier, A Merouani, S A Davidson, and R W Schrier. 1997. “Increased Nephrotoxicity of Combination Taxol and Cisplatin Chemotherapy in Gynecologic Cancers as Compared to Cisplatin Alone.” American Journal of Nephrology 17 (1): 53–58. doi:10.1159/000169072.